Beyond Air, Inc. (XAIR)
NASDAQ: XAIR · Real-Time Price · USD
0.442
+0.002 (0.45%)
At close: Aug 30, 2024, 4:00 PM
0.441
-0.001 (-0.23%)
After-hours: Aug 30, 2024, 6:06 PM EDT
Beyond Air Revenue
Beyond Air had revenue of $683.00K in the quarter ending June 30, 2024, with 1,057.63% growth. This brings the company's revenue in the last twelve months to $1.78M, up 2,922.03% year-over-year. In the fiscal year ending March 31, 2024, Beyond Air had annual revenue of $1.16M.
Revenue (ttm)
$1.78M
Revenue Growth
+2,922.03%
P/S Ratio
9.12
Revenue / Employee
$16,664
Employees
107
Market Cap
20.56M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
MEI Pharma | 66.75M |
Cosmos Health | 56.45M |
ImmunoPrecise Antibodies | 17.84M |
bioAffinity Technologies | 7.32M |
NeurAxis | 2.27M |
Lyra Therapeutics | 1.82M |
Virax Biolabs Group | 156.42K |
Bullfrog AI | 65.00K |
XAIR News
- 4 weeks ago - Beyond Air® Publishes Peer-Reviewed Journal Article in Scientific Reports with Clinical Data Showing Nitric Oxide was Safe and Beneficial Adjunct Therapy for Subjects with Viral Pneumonia - GlobeNewsWire
- 5 weeks ago - Beyond Air® to Report First Fiscal Quarter 2025 Financial Results on August 6 - GlobeNewsWire
- 6 weeks ago - Beyond Air® To Participate in the BTIG Virtual Biotechnology Conference 2024 - GlobeNewsWire
- 2 months ago - Beyond Air, Inc. (XAIR) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Beyond Air® Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Enerpac Tool Group, Singular Genomics Systems And 3 Stocks To Watch On Monday - Benzinga
- 2 months ago - Beyond Air® Appoints David Webster as Chief Commercial Officer - GlobeNewsWire
- 3 months ago - Beyond Cancer Presents First-in-Class Clinical Data Showing an Immunogenic Response in Subjects with r/r Unresectable Solid Tumors Treated with Ultra-High Concentration Nitric Oxide (UNO) - GlobeNewsWire